The companies said Monday the tender offer covers 7,424,366 shares of Class A common stock and 4,500,000 shares of Class B common stock at NCI.
The offer’s completion works to enable the acquisition deal to push through with a merger between an H.I.G. affiliate and NCI on Aug. 15.
NCI will become a privately held, indirect wholly owned subsidiary of the H.I.G. affiliate and the NCIT common stock will cease trading under Nasdaq upon the acquisition’s close, the companies added.
The Federal Trade Commission also recently cleared the planned acquisition through antitrust checks and approved an early termination of the waiting period for the deal under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.